Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2003
11/19/2003CN1456165A Method for increasing solubility of parabuxinidine-D injection
11/19/2003CN1456151A Preparing method for sustained releasing huperzine preparation
11/19/2003CN1127986C Preparation of medicinal carrier precursor liposome
11/19/2003CN1127985C Fowl marek's disease vaccine synergist and its preparation
11/19/2003CN1127955C Medicine for treating immune relative disease of anterior chamber and surface of eye
11/18/2003US6649742 Fusion protein comprising gelonin and a antibody fused thereto; cytolysis; use in treatment of cancer, autoimmune and graft-versus-host disease
11/18/2003US6649659 Atovaquone pharmaceutical compositions
11/18/2003US6649652 Prodrugs for antimicrobial amidines
11/18/2003US6649599 Immunoisolation of preferential cells; obtain cells, incubate with n-acetylglucosamine, encapsulate, recover cells
11/18/2003US6649591 Dithiocarbamates linked to the surface of a non-immunogenic, non-targeting macromolecule other than an antibody (e.g., albumin protein); treating cerebral stroke and other ischemia/reperfusion injury
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/18/2003US6649577 Lipids, emulsifiers and lipophilic constituents and ethylene glycol-hydroxystearate block copolymer surfactant with non-polar lipids and/or silicones
11/18/2003US6649386 Stability; for reconstitution with water; antihemophilic factor; blood factor IX
11/18/2003US6649193 Biomedically acceptable, cage-like compounds, including cobalamin (vitamin B12), potassium silicate and colloidal silicates and aluminosilicates such as zeolites encage atomic hydrogen in a
11/18/2003US6649189 Screening activities of eukaryotic tissues; obtain sample tissue, incubate with modulator, monitor cellular activity of tissues
11/18/2003US6649186 Effervescent granules and methods for their preparation
11/18/2003US6649185 For the treatment of cancer; particularly, the formulation can be used to treat haematological malignancies
11/18/2003US6649180 Hard capsule formed of cellulose ether film with a specific content of methoxyl and hydroxypropoxyl groups
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003US6649168 Pharmaceutical compositions comprising TGF-beta
11/18/2003US6649147 Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/18/2003US6649145 Wound healing, treating infections
11/18/2003CA2223433C Ob protein compositions and methods
11/18/2003CA2136071C 2-arylpropionic acid compositions and process for preparing the same
11/18/2003CA2109952C Pharmaceutical compositions
11/13/2003WO2003093793A2 Binary or polynary targeting and uses thereof
11/13/2003WO2003093498A1 Inhibition of protein tyrosine phosphatases and sh2 domains by a neutral phosphotyrosine mimetic
11/13/2003WO2003093478A1 Immunoconjugates for the treatment of tumours
11/13/2003WO2003093469A2 Methods for delivering nucleic acid molecules into cells and assessment thereof
11/13/2003WO2003093462A2 Immobilisation and stabilisation of virus
11/13/2003WO2003093449A2 Methods for delivery of nucleic acids
11/13/2003WO2003093346A1 Multifunctional polyethylene glycol derivatives: preparation and use
11/13/2003WO2003093344A1 Polymeric microemulsions
11/13/2003WO2003093315A2 Specific antibody fragments for the human carcinoembryonic antigen (cea)
11/13/2003WO2003093303A1 Targeting proteins to deliver therapeutic or diagnostic reagents
11/13/2003WO2003093299A2 Insulin-associated peptides with effects on cerebral health
11/13/2003WO2003093243A1 Preparations for the topical application of anti-androgenically active substances
11/13/2003WO2003092785A1 Arrays of microneedles comprising porous calcium phosphate coating and bioactive agents
11/13/2003WO2003092742A1 Vitamin-targeted imaging agents
11/13/2003WO2003092741A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/13/2003WO2003092740A1 Non-viral gene delivery system
11/13/2003WO2003092739A1 Non-viral gene delivery system
11/13/2003WO2003092738A1 Drug- or gene-carrier composition having lowered hemagglutinin activity
11/13/2003WO2003092737A1 Fusions of cytokines and tumor targeting proteins
11/13/2003WO2003092736A2 Peptide nucleic acid conjugates with transporter peptides
11/13/2003WO2003092735A2 Peptide nucleic acid conjugates with beta-amino acid polymers or reptoids
11/13/2003WO2003092734A1 Temperature responsive delivery systems
11/13/2003WO2003092732A1 Ph-sensitive polymer
11/13/2003WO2003092731A1 Stabilised solid compositions of modified factor vii
11/13/2003WO2003092728A1 Encapsulated cells to elicit immune response
11/13/2003WO2003092707A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
11/13/2003WO2003092706A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003WO2003092704A1 External preparation enhanced in systemic property of vidarabine
11/13/2003WO2003092677A1 Trans-epicutaneous administration form for treating restless leg syndrome
11/13/2003WO2003092660A1 Monocompartment osmotic controlled drug delivery system
11/13/2003WO2003092659A1 Oral dosage forms comprising fenofibrate
11/13/2003WO2003092657A1 Microparticles bearing cells and active substances
11/13/2003WO2003092656A1 Chemically and/or biologically reactive compouds
11/13/2003WO2003092654A1 Formulations limiting spread of pulmonary infections
11/13/2003WO2003092652A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003WO2003092651A1 Warming and nonirritating lubricant compositions
11/13/2003WO2003092650A1 Warming and nonirritating lubricant antifungal gel compositions
11/13/2003WO2003092649A2 Reduced formate poly(alkylene oxides) with secondary amines for reducing impurity formation
11/13/2003WO2003092648A1 Methods and dosage forms for controlled delivery of oxycodone
11/13/2003WO2003092647A2 Transport system in biological systems
11/13/2003WO2003092641A1 Topical glycopyrrolate product
11/13/2003WO2003092640A2 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units
11/13/2003WO2003092633A2 Diffusion-controlled dosage form and method of fabrication including three dimensional printing
11/13/2003WO2003092626A2 Carvedilol pharmasolve solvate
11/13/2003WO2003092625A2 Carvedilol formulations
11/13/2003WO2003092623A2 Calicheamicin derivative-carrier conjugates
11/13/2003WO2003092621A2 Composition and method for dermatological treatment
11/13/2003WO2003092613A2 Catechin multimers as therapeutic drug delivery agents
11/13/2003WO2003092608A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof
11/13/2003WO2003092596A2 TREATING ECZEMA WITH A COMBINATION OF ISOTONIC SALINE OCEANè AND MAST CELL STABILIZERS
11/13/2003WO2003092590A2 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
11/13/2003WO2003092585A2 Controlled release compositions of estradiol metabolites
11/13/2003WO2003092580A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003WO2003092400A1 Sugar-free hard coatings prepared from liquid maltitol comprising dp4+ fraction
11/13/2003WO2003080056A3 Fine particle size pioglitazone
11/13/2003WO2003077883A3 Composition and utilization thereof for forming a protective film on nasal mucous membranes
11/13/2003WO2003075826A3 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease)
11/13/2003WO2003070174A3 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
11/13/2003WO2003068185A3 Use of buckysome or carbon nanotube for drug delivery
11/13/2003WO2003066001A3 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
11/13/2003WO2003064614A3 Transport peptides and uses therefor
11/13/2003WO2003063839A8 Bioadhesive composition comprising a polysaccharide and a polycarboxylated polymer
11/13/2003WO2003063822A3 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
11/13/2003WO2003063821A3 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
11/13/2003WO2003061554A3 Composition containing moutan root bark extract as active ingredient
11/13/2003WO2003057175A3 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor
11/13/2003WO2003052060A3 Beta-cyclodextrin dimers and phthalocyanines and uses thereof
11/13/2003WO2003045305A3 Acetaminophen compositions
11/13/2003WO2003043585A3 Improved particulate compositions for pulmonary delivery
11/13/2003WO2003042244A3 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
11/13/2003WO2003041648A3 High-concentration lidocaine compositions and methods for their preparation
11/13/2003WO2003039444A3 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003032948A3 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity
11/13/2003WO2003031593A3 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 1712